Science Explorer Back to mapMap
Discussion
Company · Lianyun · China

Kanion Pharmaceutical (China)

In research, Kanion Pharmaceutical (China) stands highest in Life Sciences (#4,099 of 11,023 worldwide), Health Sciences (#7,375 of 16,688 worldwide) and Medicine (#8,058 of 14,558 worldwide), over all time. Relative to its size it is most specialised in Molecular Biology (Molecular Biology is 6.8× its share of world research).

World rank, 2022-now
#20,754
of 22,385 · #13,503 all time
Rank in China
#2,337
of 2,481
Research works
530
▲ 10% vs 2018-21
Citations
6.7k
12.7 per fractional work
Top-10% rate
10.4%
all institutions 10.0%
vs its own fields
0.99×
1.00× is exactly expected
Open access
20%
world 40%
International
6%
world 18%

What is Kanion Pharmaceutical (China) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #4,099 of 11,023 7.1%247
Health SciencesDomain #7,375 of 16,688 7.2%201
MedicineField #8,058 of 14,558 7.3%194

Each strip is that field's whole ranked pool, with the notch where Kanion Pharmaceutical (China) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Kanion Pharmaceutical (China) work in?

In 2022-now, 51% of research at Kanion Pharmaceutical (China) is in Life Sciences, 30% in Health Sciences. Its largest fields are Medicine (29%), Biochemistry, Genetics and Molecular Biology (27%), Pharmacology, Toxicology and Pharmaceutics (9%). It does 3.4× the world's share of Life Sciences.

Life Sciences: 60 fractional works · 50.9% of its workBiochemistry, Genetics and Molecular Biology: 32 fractional works · 26.9% of its workMolecular Biology: 24 fractional works · 20.7% of its workCancer Research: 2 fractional works · 2.1% of its workGenetics: 1 fractional works · 1.0% of its workBiotechnology: 1 fractional works · 1.0% of its workBiochemistry: 1 fractional works · 0.9% of its workCell Biology: 1 fractional works · 0.5% of its workBiophysics: 0 fractional works · 0.4% of its workMolecular Medicine: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 10 fractional works · 8.9% of its workPharmacology: 9 fractional works · 7.9% of its workPharmaceutical Science: 1 fractional works · 0.6% of its workToxicology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 10 fractional works · 8.9% of its workPlant Science: 6 fractional works · 4.8% of its workFood Science: 3 fractional works · 2.6% of its workAquatic Science: 1 fractional works · 0.5% of its workAnimal Science and Zoology: 0 fractional works · 0.4% of its workAgronomy and Crop Science: 0 fractional works · 0.3% of its workInsect Science: 0 fractional works · 0.3% of its workImmunology and Microbiology: 4 fractional works · 3.4% of its workImmunology: 3 fractional works · 2.9% of its workMicrobiology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 3 fractional works · 2.8% of its workNeurology: 2 fractional works · 1.8% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workBehavioral Neuroscience: 0 fractional works · 0.3% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Sciences: 36 fractional works · 30.3% of its workMedicine: 34 fractional works · 28.9% of its workComplementary and alternative medicine: 9 fractional works · 7.6% of its workPharmacology: 5 fractional works · 4.0% of its workPulmonary and Respiratory Medicine: 4 fractional works · 3.0% of its workOncology: 2 fractional works · 2.1% of its workEpidemiology: 2 fractional works · 2.0% of its workPhysiology: 2 fractional works · 1.8% of its workPathology and Forensic Medicine: 1 fractional works · 1.2% of its workRehabilitation: 1 fractional works · 0.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.6% of its workSurgery: 1 fractional works · 0.5% of its workDermatology: 1 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workNephrology: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.3% of its workHealth Informatics: 0 fractional works · 0.3% of its workSmaller subfields together: 2 fractional works · 1.6% of its workNursing: 1 fractional works · 0.6% of its workNutrition and Dietetics: 1 fractional works · 0.6% of its workHealth Professions: 1 fractional works · 0.5% of its workEmergency Medical Services: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workPhysical Sciences: 21 fractional works · 17.8% of its workChemistry: 8 fractional works · 7.0% of its workOrganic Chemistry: 3 fractional works · 2.7% of its workAnalytical Chemistry: 3 fractional works · 2.3% of its workSpectroscopy: 2 fractional works · 1.4% of its workInorganic Chemistry: 0 fractional works · 0.4% of its workElectrochemistry: 0 fractional works · 0.3% of its workEngineering: 5 fractional works · 3.8% of its workBiomedical Engineering: 1 fractional works · 1.2% of its workControl and Systems Engineering: 1 fractional works · 1.0% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workMechanical Engineering: 0 fractional works · 0.3% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.6% of its workComputer Science: 3 fractional works · 2.8% of its workComputational Theory and Mathematics: 2 fractional works · 1.3% of its workArtificial Intelligence: 1 fractional works · 1.0% of its workInformation Systems: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEnvironmental Science: 3 fractional works · 2.2% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 0.7% of its workEcology: 1 fractional works · 0.5% of its workWater Science and Technology: 1 fractional works · 0.5% of its workPollution: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 1 fractional works · 1.0% of its workBiomaterials: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workPolymers and Plastics: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 1 fractional works · 0.7% of its workOceanography: 1 fractional works · 0.7% of its workEnergy: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 0.9% of its workDecision Sciences: 1 fractional works · 0.5% of its workManagement Science and Operations Research: 1 fractional works · 0.5% of its workPsychology: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.0% of its workALL ITS WORKKanionPharmaceutical…118fractional works, 2022-now
Life Sciences51%Physical Sciences18%Health Sciences30%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3226.9%
    2. Pharmacology, Toxicology and Pharmaceutics108.9%
    3. Agricultural and Biological Sciences108.9%
    4. Immunology and Microbiology43.4%
    5. Neuroscience32.8%
    1. Medicine3428.9%
    2. Nursing10.6%
    3. Health Professions10.5%
    4. Veterinary00.3%
    1. Chemistry87.0%
    2. Engineering53.8%
    3. Computer Science32.8%
    4. Environmental Science32.2%
    5. Materials Science11.0%
    6. Earth and Planetary Sciences10.7%
    7. Energy00.2%
    8. Chemical Engineering00.1%
    1. Decision Sciences10.5%
    2. Psychology00.2%
    3. Social Sciences00.1%
    4. Economics, Econometrics and Finance00.1%
    5. Business, Management and Accounting00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Kanion Pharmaceutical (China) specialise in?

Where its research is concentrated relative to its size: Molecular Biology takes 6.8× the share of its output that it takes of world research.

  1. Molecular BiologySubfield · 24.3 works6.8×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.87× its world share, 10 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.05× its world share, 32 worksBiochemistry, Geneti…Immunology and Microbiology: 3.41× its world share, 4 worksImmunology and Micro…Neuroscience: 1.72× its world share, 3 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 25.24× its world share, 10 worksPharmacology, Toxico…Chemical Engineering: 0.27× its world share, 0 worksChemical EngineeringChemistry: 4.45× its world share, 8 worksChemistryComputer Science: 0.36× its world share, 3 worksComputer ScienceEarth and Planetary Sciences: 0.45× its world share, 1 worksEarth and Planetary …Energy: 0.20× its world share, 0 worksEnergyEngineering: 0.26× its world share, 4 worksEngineeringEnvironmental Science: 0.44× its world share, 3 worksEnvironmental ScienceMaterials Science: 0.28× its world share, 1 worksMaterials ScienceHealth Professions: 0.19× its world share, 1 worksHealth ProfessionsMedicine: 1.51× its world share, 34 worksMedicineNursing: 1.25× its world share, 1 worksNursingVeterinary: 2.09× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Decision Sciences: 0.51× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.04× its world share, 0 worksEconomics, Econometr…Psychology: 0.05× its world share, 0 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 25.2×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics25.24×10 works
  2. Biochemistry, Genetics and Molecular Biology5.05×32 works
  3. Chemistry4.45×8 works
  4. Immunology and Microbiology3.41×4 works
  5. Veterinary2.09×0 works
  6. Agricultural and Biological Sciences1.87×10 works
  7. Neuroscience1.72×3 works
  8. Medicine1.51×34 works
  9. Nursing1.25×1 works
  10. Decision Sciences0.51×1 works
  11. Earth and Planetary Sciences0.45×1 works
  12. Environmental Science0.44×3 works
  13. Computer Science0.36×3 works
  14. Materials Science0.28×1 works
  15. Chemical Engineering0.27×0 works
  16. Engineering0.26×4 works
  17. Energy0.20×0 works
  18. Health Professions0.19×1 works
  19. Psychology0.05×0 works
  20. Economics, Econometrics and Finance0.04×0 works
  21. Business, Management and Accounting0.01×0 works
  22. Social Sciences0.01×0 works

Who are the top researchers at Kanion Pharmaceutical (China)?

Ranked on the quality score, Zeyu Cao, Qian Zhao and Haibo Li lead among researchers whose main affiliation is Kanion Pharmaceutical (China).

  1. 1 Zeyu Cao China · #1,333,863 worldwide 2.1k citations · 70 works
  2. 2 Qian Zhao China · #1,382,487 worldwide 796 citations · 44 works
  3. 3 Haibo Li China · #1,566,840 worldwide 1.2k citations · 76 works
  4. 4 Wei Lie Xiao China · #2,876,802 worldwide 1k citations · 66 works
  5. 5 Wei Xiao China · #3,106,728 worldwide 413 citations · 21 works
  6. 6 Xue Xie China · #3,298,474 worldwide 124 citations · 25 works
  7. 7 Yukai Cao China · #3,376,549 worldwide 181 citations · 18 works
  8. 8 Zhen-Zhen Su China · #3,459,250 worldwide 292 citations · 27 works
  9. 9 Xialin Chen China · #3,598,518 worldwide 946 citations · 94 works
  10. 10 Mengyu Qian China · #3,696,691 worldwide 243 citations · 52 works
All ranked researchers at Kanion Pharmaceutical (China)

What are the most cited papers from Kanion Pharmaceutical (China)?

The most cited paper from Kanion Pharmaceutical (China) is "Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol" (Jingqiu Wang, Xianying Fang, Lin Ge et al., 2018), with 351 citations. Next come "Antioxidant and anti-inflammatory activities of six flavonoids separated from licorice" (317) and "Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective" (305).

Most cited papers
#PaperReleasedCitations
1 Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol Jingqiu Wang, Xianying Fang, Lin Ge et al. · PLoS ONE Open access 17 May 2018 351
2 Antioxidant and anti-inflammatory activities of six flavonoids separated from licorice Yu Fu, Jun Chen, Yanjing Li et al. · Food Chemistry 16 Apr 2013 317
3 Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective Yong-Sheng Zhang, Xinjie Liang, Xuefei Bao et al. · European Journal of Medicinal Chemistry Open access 14 Mar 2022 305
4 LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond Wanxu Huang, Hua Li, Qingsong Yu et al. · Journal of Experimental & Clinical Cancer Research Open access 15 Mar 2022 220
5 Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets Xin Wang, Pablo Binder, Qiru Fang et al. · British Journal of Pharmacology Open access 26 May 2017 217
All 60 most cited papers, with filters and sorting

Which keywords describe research at Kanion Pharmaceutical (China)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Antioxidant, Cancer, Anti-inflammatory, Inflammation, Herbal Medicine, Traditional Chinese Medicine, Antiviral and Bioactive Compounds.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Antioxidant19▲ 23×26 topics
  2. Cancer18▲ 11×34 topics
  3. Inflammation14▲ 5.7×43 topics
  4. Anti-inflammatory13▲ 40×16 topics
  5. Herbal Medicine10▲ 32×7 topics
  6. Traditional Chinese Medicine10▲ 74×5 topics
  7. Antiviral10▲ 106×3 topics
  8. Bioactive Compounds10▲ 33×5 topics
  9. Pharmacology9▲ 30×15 topics
  10. Phytochemistry8▲ 56×4 topics
  11. Oxidative Stress8▲ 3.9×30 topics
  12. Antioxidant Activity7▲ 9.5×13 topics
  13. Biological Activities7▲ 37×5 topics
  14. Hepatoprotective7▲ 66×3 topics
  15. Pharmacokinetics7▲ 21×9 topics
  16. Pharmacological Effects6▲ 84×5 topics
  17. Flavonoids6▲ 21×9 topics
  18. Medicinal Plants6▲ 13×9 topics
  19. Metabolism6▲ 9.6×16 topics
  20. Precision Medicine6▲ 9.6×5 topics
  21. Apoptosis5▲ 15×13 topics
  22. Anticancer5▲ 28×10 topics
  23. Cardiovascular Disease5▲ 4.0×7 topics
  24. Glycyrrhizin5▲ 127×1 topic
  25. Licorice5▲ 127×1 topic
  26. Neuroprotective4▲ 22×10 topics
  27. Triterpenoids4▲ 55×3 topics
  28. Neuroprotective Effects4▲ 22×7 topics
  29. Chemical Analysis4▲ 58×1 topic
  30. Quality Control4▲ 18×1 topic
  31. Saponins4▲ 87×2 topics
  32. Adjuvants4▲ 97×1 topic
  33. Ethnopharmacology4▲ 55×3 topics
  34. Pharmacological Properties4▲ 37×1 topic
  35. Reactive Oxygen Species3▲ 6.6×10 topics
  36. Genomic Analysis3▲ 9.7×4 topics
  37. Genomics3▲ 8.3×3 topics
  38. Mass Spectrometry3▲ 16×3 topics
  39. Data Analysis3▲ 9.1×3 topics
  40. Iridoids3▲ 73×1 topic

Which research topics does Kanion Pharmaceutical (China) publish most on?

By volume in 2022-now: Pharmacological Effects of Natural Compounds, Traditional Chinese Medicine Analysis, Natural product bioactivities and synthesis and Phytochemistry and Biological Activities.

  1. 1 Pharmacological Effects of Natural Compounds Pharmacology 5 works
  2. 2 Traditional Chinese Medicine Analysis Complementary and alternative medicine 4 works
  3. 3 Natural product bioactivities and synthesis Molecular Biology 4 works
  4. 4 Phytochemistry and Biological Activities Plant Science 3 works
  5. 5 Traditional Chinese Medicine Studies Complementary and alternative medicine 3 works
  6. 6 Metabolomics and Mass Spectrometry Studies Molecular Biology 2 works
  7. 7 Gut microbiota and health Molecular Biology 2 works
  8. 8 Chromatography in Natural Products Analytical Chemistry 2 works
  9. 9 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
  10. 10 Ginger and Zingiberaceae research Pharmacology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available19.6%not open80.4%

World: 40% of research is openly available.

with international co-authors6.3%domestic only93.7%

World: 18% is written across borders.

How has Kanion Pharmaceutical (China)'s research output changed?

Output in 2022-2025 was 10% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Kanion Pharmaceutical (China) as a percentage of every work published that year, 0.00053% in 2024.

still counting0.0010%0.0020%Kanion Pharmaceutical (China)0.00061% in 202520102020

Fractional works of Kanion Pharmaceutical (China) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%all institutions10.0% in 2025Kanion Pharmaceutical (China)6.6% in 20252020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 15.0% in 2022.

Other research institutions in Lianyun

All research institutions in Lianyun

Share Kanion Pharmaceutical (China)'s ranking

Kanion Pharmaceutical (China) on Science Explorer

A card with Kanion Pharmaceutical (China)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Kanion Pharmaceutical (China). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.